icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2024
Nov 15-19,
San Diego, CA
Back grey_arrow_rt.gif
 
 
 
Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis Delta Receiving Bulevirtide With or Without Pegylated Interferon Alfa-2a in MYR204
 
 
 
he Liver Meeting, American Association for the Study of Liver Diseases; November 15-19, 2024; San Diego, CA
 
Yang Liu1, Jiani Li1, Silvia Chang1, Yu Hu1, Simin Xu1, Ross Martin1, Dmitry Manuilov1, Renee-Claude Mercier1, Audrey H Lau1, Tarik Asselah2, Fabien Zoulim3, Vladimir Chulanov4, Hongmei Mo1, Evguenia Maiorova1 1Gilead Sciences, Inc., Foster City, CA, USA; 2Hôpital Beaujon APHP, Université de Paris-Cité, INSERM UMR1149, Clichy, France; 3Hepatology Department, Hospices Civils de Lyon, INSERM, Université Claude Bernard Lyon 1, Lyon, France; 4Infectious Diseases Department, Sechenov University, Moscow, Russian Federation

1204241

1204242

1204243

1204244

1204245

1204246

1204247